Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

6.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.3K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.3K
Clinical Trials01:16

Clinical Trials

11.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.1K
Vaccinations01:51

Vaccinations

53.1K
Overview
53.1K
Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Development of Immunocompetence01:22

Development of Immunocompetence

1.1K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5-6 Years After Primary Vaccination in Adults ≥50 Years.

Open forum infectious diseases·2026
Same author

Safety and immunogenicity of a cytomegalovirus (CMV) recombinant glycoprotein B (gB) vaccine in combination with polyacrylate or an emulsion-based adjuvants.

Vaccine·2026
Same author

Pembrolizumab and stereotactic body radiotherapy combined in advanced hepatocellular carcinoma post sorafenib - A phase II trial (PEMRAD).

JHEP reports : innovation in hepatology·2026
Same author

Osimertinib and Stereotactic Radiosurgery for Brain Metastases in EGFR-Mutated Lung Cancer: The STARLET Joint Analysis of OUTRUN and LUOSICNS Randomized Trials.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

Polyfunctional T peripheral helper cells are associated with the magnitude and durability of antibody responses after COVID-19.

Clinical & translational immunology·2025
Same author

More than half of shoulder vaccinations may end up in the subacromial space.

NPJ vaccines·2025

Related Experiment Video

Updated: Mar 13, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.3K

Vaccine development: From concept to early clinical testing.

Anthony L Cunningham1, Nathalie Garçon2, Oberdan Leo3

  • 1Westmead Institute, The Centre for Virus Research, 176 Hawkesbury Road, NSW 2145, Australia.

Vaccine
|October 23, 2016
PubMed
Summary
This summary is machine-generated.

Modern microbiology and molecular tools enable precise antigen identification for advanced vaccine design, optimizing immune responses against pathogens. This approach integrates pathogen biology, immunology, and formulation science for effective vaccine development.

Keywords:
Adaptive immunityAdjuvantsAntigenClinical developmentInnate immunityVaccine

More Related Videos

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.9K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.3K

Related Experiment Videos

Last Updated: Mar 13, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.3K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.9K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

9.3K

Area of Science:

  • Microbiology and Immunology
  • Vaccine Development and Design
  • Molecular Biology

Background:

  • 21st-century advancements in microbiology and molecular techniques facilitate specific antigen identification for novel vaccine development.
  • Understanding of immune system function and host-pathogen interactions drives rational vaccine design strategies.
  • The vaccine design toolbox encompasses diverse platforms including whole pathogens, subunit vaccines, pathogen-like particles, and vector-based systems, enhanced by adjuvants and conjugation technology.

Purpose of the Study:

  • To review the integrated processes involved in modern vaccine development, from antigen identification to preclinical and clinical testing.
  • To highlight how advancements in molecular biology and immunology enable the rational design and optimization of vaccine-induced protective immune responses.
  • To illustrate these processes using examples such as human papillomavirus, malaria, and Ebola vaccines.

Main Methods:

  • Integration of knowledge on pathogen life-cycle, epidemiology, and disease mechanisms for antigen identification.
  • Analysis of host immune control, immune escape strategies, and correlates of protection to guide antigen selection and desired immune response.
  • Application of recombinant DNA technology for simplified manufacturing and consistent antigen production.

Main Results:

  • Antigen selection and formulation are critical for ensuring immunogenicity, stability, and protective efficacy of candidate vaccines.
  • Recombinant DNA technology streamlines the manufacturing process, enabling large-scale, consistent production of vaccine antigens.
  • Successful vaccine development necessitates a multidisciplinary approach, integrating pathogen biology, immunology, formulation science, and rigorous testing.

Conclusions:

  • Modern vaccine development relies on a comprehensive understanding of pathogen characteristics and host immune responses.
  • Rational design, informed by scientific advancements, optimizes the induction of protective immunity against specific immunogens.
  • Rigorous preclinical and clinical evaluation is essential to confirm the safety and efficacy of novel vaccine candidates.